Novo Nordisk Report Shows Bright Spots Amid Price Pressure -- Market Talk

Dow Jones

May 18

1310 GMT - Novo Nordisk's report had some bright spots, with the development of its obesity business the main positive, Sydbank's Soren Lontoft Hansen writes. Overall though, first-quarter earnings were characterized by pricing pressure in the commercial segment, just as the Most Favored Nation pricing agreement with the Trump administration has led to lower prices in the cash paying segment in the U.S., Hansen adds. Despite the pricing impact, Sydbank says that the Danish pharmaceutical company is showing the first early signs that it can offset lower prices with increased volume growth. "Although uncertainty is high right now, in our opinion the share price still reflects some very bleak earnings scenarios," Hansen says. "We consider the earnings scenarios to be too bleak in relation to the opportunities that exist." Shares fall 3.9%. (dominic.chopping@wsj.com)

(END) Dow Jones Newswires

May 18, 2026 09:10 ET (13:10 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2636076199"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2636076199\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2636076199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 21:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2636076199","market":"nz","top_or_hot":-1,"title":"Novo Nordisk Report Shows Bright Spots Amid Price Pressure -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1310 GMT - <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s report had some bright spots, with the development of its obesity business the main positive, Sydbank's Soren Lontoft Hansen writes. Overall though, first-quarter earnings were characterized by pricing pressure in the commercial segment, just as the Most Favored Nation pricing agreement with the Trump administration has led to lower prices in the cash paying segment in the U.S., Hansen adds. Despite the pricing impact, Sydbank says that the Danish pharmaceutical company is showing the first early signs that it can offset lower prices with increased volume growth. \"Although uncertainty is high right now, in our opinion the share price still reflects some very bleak earnings scenarios,\" Hansen says. \"We consider the earnings scenarios to be too bleak in relation to the opportunities that exist.\" Shares fall 3.9%. (dominic.chopping@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 18, 2026 09:10 ET (13:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk Report Shows Bright Spots Amid Price Pressure -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk Report Shows Bright Spots Amid Price Pressure -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-18 21:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1310 GMT - <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s report had some bright spots, with the development of its obesity business the main positive, Sydbank's Soren Lontoft Hansen writes. Overall though, first-quarter earnings were characterized by pricing pressure in the commercial segment, just as the Most Favored Nation pricing agreement with the Trump administration has led to lower prices in the cash paying segment in the U.S., Hansen adds. Despite the pricing impact, Sydbank says that the Danish pharmaceutical company is showing the first early signs that it can offset lower prices with increased volume growth. \"Although uncertainty is high right now, in our opinion the share price still reflects some very bleak earnings scenarios,\" Hansen says. \"We consider the earnings scenarios to be too bleak in relation to the opportunities that exist.\" Shares fall 3.9%. (dominic.chopping@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 18, 2026 09:10 ET (13:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1093756325.SGD","symbol_name":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2636076199","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2636076199","pubTimestamp":1779109800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1310 GMT - Novo Nordisk's report had some bright spots, with the development of its obesity business the main positive, Sydbank's Soren Lontoft Hansen writes. Overall though, first-quarter earnings were characterized by pricing pressure in the commercial segment, just as the Most Favored Nation pricing agreement with the Trump administration has led to lower prices in the cash paying segment in the U.S., Hansen adds. Despite the pricing impact, Sydbank says that the Danish pharmaceutical company is showing the first early signs that it can offset lower prices with increased volume growth. \"Although uncertainty is high right now, in our opinion the share price still reflects some very bleak earnings scenarios,\" Hansen says. \"We consider the earnings scenarios to be too bleak in relation to the opportunities that exist.\" Shares fall 3.9%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","NVO":"诺和诺德","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4588":"碎股","NVOX":"2倍做多NVO ETF-Defiance","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4585":"ETF&股票定投概念","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","BK4007":"制药","NVOH":"Novo Nordisk A/S B Shares ADRhedged"},"translate_title":"诺和诺德报告在价格压力下显示亮点——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVOH":0.6,"NVOX":0.6,"NVO":1.95},"content_text":"1310 GMT - Novo Nordisk's report had some bright spots, with the development of its obesity business the main positive, Sydbank's Soren Lontoft Hansen writes. Overall though, first-quarter earnings were characterized by pricing pressure in the commercial segment, just as the Most Favored Nation pricing agreement with the Trump administration has led to lower prices in the cash paying segment in the U.S., Hansen adds. Despite the pricing impact, Sydbank says that the Danish pharmaceutical company is showing the first early signs that it can offset lower prices with increased volume growth. \"Although uncertainty is high right now, in our opinion the share price still reflects some very bleak earnings scenarios,\" Hansen says. \"We consider the earnings scenarios to be too bleak in relation to the opportunities that exist.\" Shares fall 3.9%. (dominic.chopping@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 09:10 ET (13:10 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}